B. coagulans GBI-30 6086.

Once the spore germinates in the small intestine the vegetative cell ferments fructans to lactic acid. Inulin supplies that substrate where the cell becomes active.

Short chain fructooligosaccharides ferment quickly in the proximal colon, matching where germinated cells are metabolising. The pairing is a straightforward substrate and organism match.

Galactooligosaccharides resist host digestion and are fermented by lactic acid producers. They widen the substrate range beyond fructan chains.

Xylooligosaccharides are fermented selectively at low doses and provide a xylose-based substrate. That complements the fructan-fermenting route.

Resistant starch reaches the colon intact and ferments more distally than oligosaccharides. Fermentation is spread further along the bowel.

Partially hydrolysed guar ferments slowly and evenly, giving a longer substrate window with a lower gas load than rapid fructans.

Enzymes cut the undigested macronutrient load arriving in the colon while the strain works microbially. Spores tolerate co-formulation because the coat resists acid and enzymatic attack.

Glutamine is the enterocyte's own fuel, while the strain lowers luminal pH and contributes short chain fatty acids for colonocytes. The two act on different sides of the epithelium.

A yeast and a spore-forming bacterium occupy separate niches and neither antagonises the other. Both pass the stomach without enteric protection.

Carvacrol and thymol permeabilise bacterial membranes without selecting between resident and supplemented organisms. Germinated vegetative cells are exposed to that action.

Berberine is broadly antibacterial in the lumen and shifts microbial composition. Germinated probiotic cells face the same pressure, so dosing is usually separated.

Germinated cells secrete proteases and peptidases that continue hydrolysing dietary protein in the lumen. Spore strains are standard in protein powders because they survive processing and storage.

Both organisms produce lactic acid and lower luminal pH, but the Bacillus arrives as a dormant spore while the Lactobacillus arrives as a vegetative cell. That difference means they survive storage and gastric transit differently, so pairing them broadens the delivery window rather than doubling one organism. Species-level microbiology, not a combination trial.

Bifidobacteria colonise the colon and ferment oligosaccharides, while this spore-former germinates higher up in the small intestine. The two occupy different segments of the gut. Pairing is a coverage decision with no joint outcome claimed.

L. plantarum is one of the more acid-tolerant lactic acid bacteria and carries a broad carbohydrate-fermenting repertoire. Combined with a spore-former, the blend covers both a vegetative and a dormant delivery route. Mechanistic complementarity only.

B. longum ferments oligosaccharides to acetate and lactate in the colon, feeding butyrate producers by cross-feeding. A spore-former acting more proximally does not compete for that niche. Complementary siting rather than measured synergy.

Lactate produced by this organism is a substrate that lactate-utilising colonic bacteria convert onward to butyrate. Supplying butyrate directly gives the end product without depending on that conversion. Two routes to the same short-chain fatty acid, one microbial and one direct.

Psyllium is a gel-forming fibre that is only partly fermented, so it changes transit and stool water as well as providing some substrate. A spore probiotic acts on the microbial side. The two work on different levers in the same gut.

Guar galactomannan is fermented in the colon to short-chain fatty acids and also raises viscosity in the small intestine. It supplies substrate downstream of where this spore germinates. Substrate chemistry, plainly labelled.

Pectin is a fermentable soluble fibre whose breakdown yields acetate and propionate. It broadens the substrate mix beyond the fructans usually paired with probiotics. No combination study is claimed for this strain.

Oat beta-glucan is both viscous and fermentable, which makes it substrate for colonic bacteria and a modifier of intestinal transit. It complements a spore probiotic acting on the microbial community. Mechanism only.

Konjac glucomannan is highly viscous and partly fermentable, so it slows transit and supplies substrate. The viscosity itself can also slow dispersion of a co-administered powder. Held at Promising because the interaction cuts both ways.

Lactoferrin sequesters iron and has selective antimicrobial activity against some Gram-negative organisms while being described as sparing lactic acid bacteria. Whether it spares a Bacillus spore preparation is not established. Marked Promising and flagged as strain-dependent.

Zinc carnosine acts on the gut lining directly, while a probiotic acts through the microbial community. The mechanisms do not overlap and neither depends on the other. Recorded as complementary, without combination data.

Vitamin D signalling influences antimicrobial peptide expression at mucosal surfaces, which is part of the same barrier picture a probiotic is used around. The two act by unrelated routes. No joint measurement is claimed.

Betaine hydrochloride lowers gastric pH, which destroys most vegetative probiotic cells. A dormant Bacillus spore is comparatively acid resistant, which is the practical reason this genus is used in acidic and processed products. The interaction is neutral to favourable here where it would be adverse for a lactobacillus.

Garlic organosulfur compounds such as allicin have broad antibacterial activity in vitro, including against Gram-positive organisms. A spore in dormant form is less exposed, but germinated cells are not. Flagged as a potential competition rather than a pairing.

Catechins bind bacterial membranes and inhibit growth of several Gram-positive species in culture. High-dose polyphenols in the same capsule are therefore worth flagging alongside a live organism. In vitro grounding only, so this is a caution not a finding.

Activated charcoal adsorbs organic molecules broadly across the gut lumen, including bacterial metabolites and co-administered actives. Co-dosing it with a live culture product works against the point of both. Separate the timing.